2016-12-19 · Notice · 2016-30399
Determination of Regulatory Review Period for Purposes of Patent Extension; TRULICITY
Dulaglutide
Open attributed record →Federal Register publication year
2016 FDA Federal Register peptide records
3 documents attributed to FDA and HHS and published in 2016, connected only through exact reviewed peptide-name matches.
2016-03-17 · Notice · 2016-05959
Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting
Liraglutide
Open attributed record →2016-03-16 · Notice · 2016-05931
Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting
Lixisenatide
Open attributed record →